The conversion of a normal cell to a cancer cell occurs in several steps and typically involves the activation of oncogenes and the inactivation of tumour suppressor and pro-apoptotic genes 1 . In many instances, inactivation of genes critical for cancer development occurs by epigenetic silencing, often involving hypermethylation of CpG-rich promoter regions 2, 3 . It remains to be determined whether silencing occurs by random acquisition of epigenetic marks that confer a selective growth advantage or through a specific pathway initiated by an oncogene [4] [5] [6] . Here we perform a genomewide RNA interference (RNAi) screen in K-ras-transformed NIH 3T3 cells and identify 28 genes required for Ras-mediated epigenetic silencing of the pro-apoptotic Fas gene. At least nine of these RESEs (Ras epigenetic silencing effectors), including the DNA methyltransferase DNMT1, are directly associated with specific regions of the Fas promoter in K-ras-transformed NIH 3T3 cells but not in untransformed NIH 3T3 cells. RNAi-mediated knockdown of any of the 28 RESEs results in failure to recruit DNMT1 to the Fas promoter, loss of Fas promoter hypermethylation, and derepression of Fas expression. Analysis of five other epigenetically repressed genes indicates that Ras directs the silencing of multiple unrelated genes through a largely common pathway. Last, we show that nine RESEs are required for anchorageindependent growth and tumorigenicity of K-ras-transformed NIH 3T3 cells; these nine genes have not previously been implicated in transformation by Ras. Our results show that Ras-mediated epigenetic silencing occurs through a specific, complex, pathway involving components that are required for maintenance of a fully transformed phenotype.
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Members of the ras oncogene family transform most immortalized cell lines, and mutations of ras genes occur in about 30% of human tumours 7 . In addition, activation of the Ras pathway is frequent in human tumours even in the absence of ras mutations 8 . Previous studies have shown that, in mouse NIH 3T3 cells, activated Ras epigenetically silences Fas expression, thereby preventing Fas-ligandinduced apoptosis 9, 10 . Activated Ras also epigenetically silences Fas expression in the human K-ras-transformed cell line, HEC1A (Supplementary Fig. 1 ). To identify genes required for Ras-mediated silencing of Fas, we performed a genome-wide small hairpin RNA (shRNA) screen using, as a selection strategy, re-expression of Fas protein on the cell surface (Fig. 1a) . A mouse shRNA library comprising about 62,400 shRNAs directed against about 28,000 genes was divided into 10 pools, which were packaged into retrovirus particles and used in the stable transduction of Fas-negative K-ras NIH 3T3 cells. Fas-positive cells in each pool were selected on immunomagnetic beads by using an anti-Fas antibody; the Fas-positive population was expanded and the shRNAs were identified by sequence analysis. Positive candidates were confirmed by stably transducing K-ras NIH 3T3 cells with single shRNAs directed against the candidate genes, followed by immunoblot analysis for Fas re-expression.
The screen identified 28 genes that, after shRNA-mediated knockdown, resulted in Fas re-expression. These genes are listed in Table 1 , and an immunoblot analysis of Fas re-expression in the 28 K-ras NIH 3T3 knockdown (K-ras NIH 3T3 KD) cell lines is shown in Fig.  1b . Consistent with previous reports 10 , treatment of K-ras NIH 3T3 cells with the DNA methylation inhibitor 5-aza-29-deoxycytidine (5-aza) restored Fas expression (see also Supplementary Fig. 1 ). Quantitative *These authors contributed equally to this work. 2 ). For all 28 genes a second, unrelated, shRNA directed against the same target also resulted in Fas re-expression when stably expressed in K-ras NIH 3T3 cells ( Supplementary Fig. 3 ). Knockdown of each of these 28 genes in an additional cell line, H-ras-transformed murine C3H10T1/2 cells, also derepressed the epigenetically silenced Fas gene ( Supplementary Fig. 4a ). For convenience we refer to the protein products of the 28 genes as RESEs. The RESEs include cytoplasmic cell signalling molecules and nuclear regulators of gene expression (Table 1) . Among the cell signalling components, PDPK1, a serine/threonine kinase, is known to function downstream of Ras and to regulate the phosphatidylinositol-3-OH kinase (PI(3)K)-Akt pathway, which is frequently activated in cancer 11 . Significantly, it has been previously reported that the PI(3)K-Akt pathway is involved in Ras-mediated silencing of Fas
.
Other cell signalling proteins include MAPK1, a proximal Ras target that is frequently activated in cancer 12 , and PTK2B, which is recruited to cell membranes by activated Ras 13 . Among the nuclear gene regulatory proteins are known transcriptional activators and repressors/co-repressors (CTCF, EID1, E2F1, RCOR2 and TRIM66/TIF1D) including several predicted sequencespecific DNA-binding proteins (SOX14, ZCCHC4 and ZFP345B), three histone methyltransferases (DOT1L, EZH2 and SMYD1), a histone deacetylase (HDCA9), two histone chaperones (ASF1A and NPM2), the maintenance DNA methyltransferase DNMT1, and several Polycomb group proteins (BMI1, EED and EZH2). Several recent studies have linked Polycomb proteins to abnormal DNA methylation and gene silencing [14] [15] [16] . One of the nuclear RESEs is BAZ2A/TIP5, previously known only to be involved in the repression of RNA polymerase I-directed ribosomal gene transcription 17 . Several RESEs were substantially upregulated at the transcriptional ( Supplementary Fig. 5 ) or post-transcriptional ( Supplementary Fig.  6 ) level in K-ras NIH 3T3 cells compared with NIH 3T3 cells, which explains, at least in part, how K-ras activates this silencing pathway.
As mentioned above, treatment of K-ras NIH 3T3 cells with 5-aza results in Fas re-expression, suggesting that repression is due, at least in part, to promoter hypermethylation. We therefore sought to determine the relationship between Fas promoter hypermethylation and Fas re-expression after knockdown of each of the 28 RESEs. We first confirmed that the repressed Fas promoter was hypermethylated and mapped the hypermethylated region(s) by bisulphite sequence analysis. These results, summarized in Fig. 2a , reveal three regions located upstream and downstream from the transcription start site (TSS) that are hypermethylated in K-ras NIH 3T3 cells but not in NIH 3T3 cells or in K-ras NIH 3T3 cells after knockdown of DNMT1. Significantly, these same three Fas promoter regions are also hypermethylated in H-ras-transformed C3H10T1/2 cells but not in C3H10T1/2 cells or in H-ras-transformed C3H10T1/2 cells after knockdown of DNMT1 ( Supplementary Fig. 4b ).
To facilitate analysis of the methylation status of these three regions in the 28 K-ras NIH 3T3 KD cell lines we established and validated a rapid methylated DNA immunoprecipitation (MeDIP) assay, in which the antibody is directed against 5-methylcytosine 18 . The MeDIP results of Supplementary Fig. 7 show that in K-ras NIH 3T3 cells the Fas promoter was hypermethylated within the TSS/downstream region, which is consistent with the bisulphite sequencing results. Moreover, the MeDIP results show, as expected, that the TSS/downstream region was not hypermethylated in NIH 3T3 cells or in K-ras NIH 3T3 cells after treatment with 5-aza. We then assessed the three hypermethylated Fas promoter regions in each of the 28 K-ras NIH 3T3 KD cell lines. The results of Fig. 2b show that in all 28 K-ras NIH 3T3 KD cell lines the three Fas promoter regions were not hypermethylated, which is consistent with the expression data.
For a better understanding of the basis of Fas silencing, we examined whether nuclear RESEs functioned by direct association with the Fas promoter. We performed a series of chromatin immunoprecipitation (ChIP) assays, based on antibody availability, using three sets of promoter-specific primer pairs located about 2 kilobases (kb) upstream of the TSS, about 1 kb upstream of the TSS or encompassing the core promoter/TSS. The three primer pairs cover the entire Fas promoter region. Figure 2c shows that in K-ras NIH 3T3 cells, nine of the RESEs were bound to specific Fas promoter regions: NPM2, TRIM66 and ZFP354B were present about 2 kb upstream of the TSS; BMI1, DNMT1, SIRT6 and TRIM37 were present about 1 kb upstream of the TSS; and EZH2, CTCF and NPM2 were present at the core promoter/TSS. In NIH 3T3 cells only NPM2 was detectably associated with the Fas promoter at the core promoter/TSS. Thus, as summarized in Fig. 2d , at least nine RESEs are recruited to specific regions of the Fas promoter in response to expression of activated Ras. The ChIP results of Fig. 2c show that DNMT1 is associated with the Fas promoter in K-ras NIH 3T3 cells but not in untransformed NIH 3T3 cells. The two other DNA methyltransferases, DNMT3A and DNMT3B, were not identified in the original shRNA screen and are not detectably associated with the Fas promoter by ChIP analysis (Supplementary Fig. 8 ). These results strongly suggest that DNMT1 is required to sustain hypermethylation of the Fas promoter in K-ras NIH 3T3 cells. To confirm this possibility, we analysed the association of DNMT1 with the Fas promoter in the 28 K-ras NIH 3T3 KD cell lines. The ChIP results of Fig. 2e show that in all 28 K-ras NIH 3T3 KD cell lines, association of DNMT1 with the Fas promoter was markedly decreased. Moreover, bisulphite sequence analysis showed that after knockdown of DNMT1 the TSS/downstream region of the Fas promoter was no longer hypermethylated (see Fig. 2a ).
Several genes in addition to Fas are known to be epigenetically silenced in ras-transformed cells. To gain insight into whether Ras mediates epigenetic silencing of different genes through common or diverse pathways, we analysed five other well-studied, epigenetically silenced genes: Sfrp1, Par4/Pawr, Plagl1, H2-K1 and Lox. A variety of evidence supports the relevance of these genes to cellular transformation and cancer (reviewed in refs [19] [20] [21] [22] [23] . The results of Fig. 3a show that, like Fas, all five genes were expressed in NIH 3T3 cells but not in K-ras NIH 3T3 cells, and were re-expressed in K-ras NIH 3T3 cells after treatment with 5-aza. Bisulphite sequence analysis confirmed that all five genes contained regions that are hypermethylated in K-ras NIH 3T3 cells but not in NIH 3T3 cells or in K-ras NIH 3T3 cells after knockdown of DNMT1 ( Supplementary Fig. 9 ). For four of these genes (Sfrp1, Par4, Plagl1 and H2-K1), the TSS was encompassed by dense hypermethylation in K-ras NIH 3T3 cells.
We next analysed the expression of Sfrp1, Par4, Plagl1, H2-K1 and Lox in the 28 K-ras NIH 3T3 KD cell lines. The qRT-PCR results of Supplementary Fig. 10 are summarized in Fig. 3b and reveal substantial overlap in the requirements of RESEs for epigenetic silencing of Fas, Sfrp1, Par4, Plagl1, H2-K1 and Lox: of the 28 RESEs required for silencing of Fas, at least 21 were also required for silencing of each of the five other genes analysed. MeDIP analysis for all five genes revealed a perfect correspondence between the RESEs required for silencing and for promoter hypermethylation ( Supplementary Fig.  11 ). These results indicate that Ras directs the epigenetic silencing of multiple, unrelated genes through a largely common pathway.
Proteins that function downstream of Ras could be essential for a fully transformed phenotype. To determine whether any of the 28 RESEs were also required for Ras-mediated transformation, we first tested the ability of the K-ras NIH 3T3 KD cell lines to grow in soft agar. Supplementary Fig. 12a shows that knockdown of any of nine RESEs (S100Z, MRGBP, BAZ2A, SMYD1, EID1, TRIM66, TRIM37, ZCCHC4 and KALRN) markedly inhibited anchorage-independent growth.
For a further characterization of the role of these nine RESEs in Ras-mediated transformation, we tested the ability of the corresponding nine K-ras NIH 3T3 KD cell lines to form tumours after subcutaneous injection in the flanks of nude mice. Supplementary  Fig. 12b shows that knockdown of SMYD1 or BAZ2A moderately inhibited tumour growth, whereas knockdown of S100Z, TRIM37, TRIM66, EID1, ZCCHC4, MRGBP or KALRN markedly inhibited tumour growth.
It is well established that in many cancers specific genes affecting cellular growth control are hypermethylated and epigenetically silenced 2, 3 . However, the mechanistic basis of epigenetic silencing is not understood. The results presented here show that oncogenic Ras directs epigenetic silencing through a specific, complex pathway involving at least 28 components (RESEs). Knockdown of any of the 28 RESEs resulted in a failure to recruit DNMT1 to the Fas promoter, loss of Fas promoter hypermethylation, and derepression of Fas expression. The vast majority of RESEs have not been previously connected to the Ras pathway; our results have therefore identified several new factors that act downstream of Ras. Nine RESEs are required for anchorage-independent growth and tumorigenicity. The identification of new components that act downstream of Ras, and are required for epigenetic silencing and complete transformation, provides potential new anti-cancer targets. 
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METHODS SUMMARY
shRNA screen. The mouse shRNA mir library (release 2.16; Open Biosystems) was used to generate ten retroviral pools, each comprising about 6,000 shRNA clones. K-ras NIH 3T3 cells were transduced with the retroviral pools, and two days later they were selected for seven days for resistance to puromycin. Faspositive cells were selected and expanded, and genomic DNA was isolated. To identify the candidate shRNAs, the shRNA region of the transduced virus was amplified by PCR, then cloned and sequenced. Individual knockdown cell lines were generated by retroviral transduction of K-ras NIH 3T3 cells with the respective shRNA. Individual shRNAs were either obtained from the Open Biosystems library or synthesized (see Supplementary Table 1) . Bisulphite sequencing. Bisulphite modification was conducted essentially as described 24 except that hydroquinone was used at a concentration of 125 mM during bisulphite treatment performed in the dark, and DNA was desalted on Qiaquick columns (Qiagen) after the bisulphite reaction. Chromatin immunoprecipitation (ChIP) and methylated DNA immunoprecipitation (MeDIP). ChIP assays were performed on extracts prepared seven days after retroviral transduction and selection with puromycin. The sequences of the primers used for amplifying the MeDIP and ChIP products are shown in Supplementary Table 2 . Quantitative real-time RT-PCR. Total RNA was isolated and reverse transcription was performed, followed by qRT-PCR. Primer sequences are provided in Supplementary Table 2 
